NIH Human Embryonic Stem Cell Registry

Detailed information for selected cell line:

Cell Line: Lis14_ Alport_3; Alport Syndrome mutation
NIH Registration Number: 0340
NIH Approval Number: NIHhESC-15-0340
Available for Distribution: Yes
Provider Restrictions: MTA and Tel Aviv Medical Center IRB amendment required

Additional Information: The embryo from which this hESC line was derived was affected with Alport Syndrome

NIH Restrictions: NIH-funded research with this line is limited to research on Alport Syndrome, consistent with the language from the informed consent document.

Submitting Organization: Tel Aviv Sourasky Medical Center
Provider Name: Dalit Ben-Yosef
Provider Phone:  
Provider Email:
Provider URL:
Approval Date: 07/16/2015

View All Lines Eligible for Use

Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page

Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:

  • (Emails that are offensive or unrelated to stem cells will be deleted.)

This page last updated on October 03, 2022 
Content Manager: 
Technical Issues: E-mail OER Webmaster